Wilson Sonsini Goodrich & Rosati advised Amerimmune on the deal. Histogen Inc., a clinical-stage therapeutics company focused on developing potential first-in-class therapeutics that ignite the body’s…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
